Veronika Debevec

Title: Veronika Debevec: Innovator in Pharmaceutical Formulations

Introduction

Veronika Debevec is a notable inventor based in Polhov Gradec, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of quick-dissolving dosage forms. Her innovative work has the potential to enhance the efficacy and convenience of medication delivery.

Latest Patents

Veronika holds a patent for a "Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid." This quick-dissolving pharmaceutical formulation includes several key components: (1) from about 35 to about 50 weight percent amoxicillin or a pharmaceutically acceptable salt thereof; (2) from about 2.0 to about 12 weight percent clavulanic acid or a pharmaceutically acceptable salt thereof; (3) from about 30 to about 40 weight percent mannitol; (4) from about 2 to about 7 weight percent crospovidone; (5) from about 0.5 to about 2.0 weight percent colloidal silicon dioxide; and (6) from about 2.0 to about 5.0 weight percent sodium stearyl fumarate. The patent also discloses a method for making a quick-dissolving pharmaceutical tablet.

Career Highlights

Veronika is currently associated with Sandoz AG, a global leader in generic pharmaceuticals. Her work at Sandoz AG focuses on developing innovative pharmaceutical formulations that improve patient outcomes. With her expertise, she has contributed to advancing the field of medicine through her research and development efforts.

Collaborations

Veronika has collaborated with several professionals in her field, including her coworkers Rok Staric and Marko Oblak. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Veronika Debevec is a pioneering inventor whose work in pharmaceutical formulations is making a significant impact in the industry. Her dedication to innovation and collaboration continues to drive advancements in medication delivery systems.